Hepatic Medicine-Evidence and Research
Leading citation impact metric from Clarivate Journal Citation Reports
papers with at least that number of citations each
State Council for Professorship (HĐGSNN) Scoring
Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)
HĐGSNN Score History
By article publication year| Year | Max Score | Evaluation Details | Source |
|---|---|---|---|
| 2026 | 1.50đ | WoS Q3(IF: 2.5) | 🔵 Computed |
| 2025 | 1.50đ | WoS Q3(IF: 1.8) | 🔵 Computed |
| 2024 | 1.50đ | WoS Q3(IF: 2.6) | 🔵 Computed |
| 2023 | 1.50đ | WoS Q3(IF: 2.1) | 🔵 Computed |
Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.
Aims & Scope
Hepatic Medicine: Evidence and Research is an international, peer-reviewed, open access, online journal. Publishing original research, reports, editorials, reviews and commentaries on all aspects of adult and pediatric hepatology in the clinic and laboratory including the following topics: Pathology, pathophysiology of hepatic disease Investigation and treatment of hepatic disease Pharmacology of drugs used for the treatment of hepatic disease Although the main focus of the journal is to publish research and clinical results in humans; preclinical, animal and in vitro studies will be published where they will shed light on disease processes and potential new therapies. Issues of patient safety and quality of care will also be considered. As of 1st April 2019, Hepatic Medicine: Evidence and Research will no longer consider meta-analyses for publication.
SCImago & Scopus Journal Intelligence
Not indexed in SCImago / Scopus databaseThis journal is currently not indexed in Scopus or is an academic publication indexed exclusively in Web of Science (WoS).
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
| Category | Index | Rank | Quartile |
|---|---|---|---|
GASTROENTEROLOGY & HEPATOLOGY | JCRESCI | 85/153 | Q3 |
GASTROENTEROLOGY & HEPATOLOGY | JCIESCI | 102/153 | Q3 |
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
| Year | Impact Factor | Articles / Year | Total Citations |
|---|---|---|---|
| 2026 | — | 3 | 0 |
| 2025 | 1.8 | 15 | 13 |
| 2024 | 2.6 | 10 | 28 |
| 2023 | 2.1 | 22 | 146 |
| 2022 | — | 13 | 140 |
| 2021 | — | 17 | 316 |
| 2020 | — | 16 | 271 |
| 2019 | — | 15 | 431 |
| 2018 | — | 14 | 429 |
| 2017 | — | 10 | 401 |
| 2016 | — | 15 | 685 |
| 2015 | — | 8 | 233 |
Journal Metrics & Citation Visualizations
Impact Factor Trend (2018–2024)
Clarivate IF trend for Hepatic Medicine-Evidence and Research
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics